Skip to content

Clinical trials

Recruiting Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Recruiting Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20191
20204
20214
20237
202410
20259
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amsterdam UMC, location VUmc2
Georgia State University2
Heinrich-Heine University, Duesseldorf2
Novartis Pharmaceuticals2
Shirley Ryan AbilityLab2
University Hospital, Basel, Switzerland2
University of California, San Francisco2
Biocad1
Bristol-Myers Squibb1
Cedars-Sinai Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting49
Multiple Sclerosis30
Multiple Sclerosis, Chronic Progressive12
Fatigue3
Autoimmune Diseases of the Nervous System2
Cognitive Dysfunction2
Hypoxia2
Nervous System Diseases2
Optic Neuritis2
Anxiety Disorders1

Trials

Showing 76 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.